Mr. McBrayer currently serves as president and CEO of AxioMed Spine, a developer of next-generation technology for degenerative spine conditions. He previously served as president and CEO of Osteotech, a provider of tissue technology.
More articles on devices:
37 spine, orthopedic devices receive FDA 510(k) clearance in September
Nevro files IPO — 6 things to know
BD buys CareFusion for $12.2B: 8 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
